molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions
Frontiers in Bioinformatics · 30.03.2026 · 6
DOI: 10.3389/fbinf.2026.1756459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 30.03.2026. Verfasst von Amal Alnouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Visual Data Science Lab, Johannes Kepler University, Linz, Austria. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Finding new uses for existing drugs, known as drug repurposing, is a widely adopted drug development strategy in the pharmaceutical industry. Computational drug repurposing leverages vast biomedical data to prioritize repurposing candidates. Once these candidates are prioritized, domain experts face the burden of evaluating their true potential.
Methods
In this work, we propose a visualization-based approach to address this challenge for a multimodal class of computational drug repurposing, where heterogeneous evidence modalities are integrated. We conducted a design study in close collaboration with domain experts, from which we derived a domain abstraction of the expert assessment process. Grounded in this abstraction, we developed an interactive visualization approach that explicitly models the expert reasoning process. We applied the proposed approach to create a prototype implementation, molIEreVIS, in the context of an operational drug repurposing pipeline. We used this prototype to collect qualitative feedback from domain experts actively engaged in assessing computational drug repurposing candidates.
Results
The results demonstrate the potential of our approach to support insights and reasoning in this process and reveal directions for enhancements and future work.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Visual Data Science Lab, Johannes Kepler University, Linz, Austria.
- Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
- Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
Zitieren
APA
Alnouri, A., Hinterreiter, A., Steinparz, C., Bajraktari, L., Burgstaller-Muehlbacher, S., Bauer, M., Alanis-Lobato, G., & Streit, M. (2026). molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1756459
Vancouver
Alnouri A, Hinterreiter A, Steinparz C, Bajraktari L, Burgstaller-Muehlbacher S, Bauer M, et al. molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1756459
BibTeX
@article{Alnouri2026,
author = {Alnouri, Amal and Hinterreiter, Andreas and Steinparz, Christian and Bajraktari, Labinot and Burgstaller-Muehlbacher, Sebastian and Bauer, Markus and Alanis-Lobato, Gregorio and Streit, Marc},
title = {molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions},
journal = {Frontiers in Bioinformatics},
year = {2026},
volume = {6},
doi = {10.3389/fbinf.2026.1756459}
}
EUVIMED